Eastman Chemical (EMN) PT Raised to $115 at Cowen

Cowen raised its price target on Eastman Chemical (NYSE: EMN) to $115.00 (from $106.00) while maintaining an Outperform rating.

Analyst Charles Neivert commented, "EMN management held an innovation day yesterday highlighting growth capabilities for specialty products through innovation. Faster growth from specialty products upgrades mix driving EPS growth. A $2 billion share repurchase program also supports EPS growth and reflects confidence for FCF growth. We maintain our Outperform and raise our price target on attractive valuation."

You May Also Be Interested In

• Incyte (INCY) PT Raised to $105 at Truist Securities
• Definium Therapeutics Inc (DFTX) PT Raised to $52 at Leerink
• Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink